Author

Abigail Xie

Memorial Sloan Kettering Cancer CenterORCID 0000-0001-6771-1980Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Abigail Xie1 paper · Memorial Sloan Kettering Cancer Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

Julia S. BrunneriD· 2 shared Katrina I. ParasiD· 2 shared Lydia W.S. FinleyiD· 2 shared Andrew L. KungiD· 1 shared Angela M. MonteroiD· 1 shared Armaan H. SiddiqueeiD· 1 shared Benjamin T. JacksoniD· 1 shared Benjamin T. Jackson· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Julia S. BrunnerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyNature Cell BiologyPeer-reviewedJan 7, 2026

p53 enables phospholipid headgroup scavenging

Jossie J. Yashinskie, Xianbing Zhu, Grace H. McGregor…·Lydia W.S. Finley

This study shows p53 enables lipid headgroup recycling during senescence by increasing phosphoethanolamine supply through autophagy and lysosomal catabolism, revealing a metabolic vulnerability in p53-activated cells.

7 citationstop 2%

humanproteomics

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedSep 5, 2025

PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma

Katrina I. Paras, Julia S. Brunner, Jacob A. Boyer…·Lydia W.S. Finley

This study shows that PAX3-FOXO1 drives metabolic vulnerabilities in rhabdomyosarcoma, making these cells sensitive to methotrexate.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky